271 related articles for article (PubMed ID: 19463322)
1. Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.
Ruiz-Nodar JM; Marín F; Lip GY
JACC Cardiovasc Interv; 2008 Jun; 1(3):329; author reply 330-1. PubMed ID: 19463322
[No Abstract] [Full Text] [Related]
2. Dual antiplatelet therapy plus oral anticoagulation: how does hemorrhagic risk impact stent selection?
Giugliano GR; Lotfi AS
JACC Cardiovasc Interv; 2008 Jun; 1(3):330; author reply 330-1. PubMed ID: 19463324
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
Persson J; Lindbäck J; Hofman-Bang C; Lagerqvist B; Stenestrand U; Samnegard A
EuroIntervention; 2011 Apr; 6(9):1046-52, 8-9. PubMed ID: 21518675
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.
Patti G; Di Sciascio G
Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304
[TBL] [Abstract][Full Text] [Related]
5. Competing pharmacological strategies during PCI-analysis of a prematurely terminated trial.
Kimmelstiel C
Catheter Cardiovasc Interv; 2011 Jun; 77(7):1010-1. PubMed ID: 21598352
[No Abstract] [Full Text] [Related]
6. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen KJ; Cuisset T; Kirchhof P; Marín F;
Thromb Haemost; 2010 Jan; 103(1):13-28. PubMed ID: 20062939
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin therapy for elective percutaneous coronary intervention: which agent to use? Does it matter?
Brener SJ
JACC Cardiovasc Interv; 2009 Nov; 2(11):1092-4. PubMed ID: 19926049
[No Abstract] [Full Text] [Related]
8. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.
Spyropoulos AC; Douketis JD
Int Angiol; 2008 Aug; 27(4):333-43. PubMed ID: 18677297
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.
Singh PP; Singh M; Bedi U; Molnar J; Arora R; Khosla S
Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):23-31. PubMed ID: 21183532
[TBL] [Abstract][Full Text] [Related]
10. Transradial pharmacology: do we need access relevant dosing to maximize outcome?
Gilchrist IC
Catheter Cardiovasc Interv; 2011 Jan; 77(1):69-71. PubMed ID: 20518002
[No Abstract] [Full Text] [Related]
11. [Platelet inhibitor and oral anticoagulants. Discontinue antithrombotic drugs before colonoscopy?].
Stiefelhagen P
MMW Fortschr Med; 2014 Sep; 156(15):22. PubMed ID: 25282925
[No Abstract] [Full Text] [Related]
12. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update.
Cuisset T; Valgimigli M; Mudra H; Muller O; Wijns W; Huber K
EuroIntervention; 2010 May; 6(1):39-45. PubMed ID: 20542796
[No Abstract] [Full Text] [Related]
13. Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.
Ghattas A; Shantsila E; Lip GY
Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):5-9. PubMed ID: 21282200
[No Abstract] [Full Text] [Related]
14. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
Cairns JA; McMurtry MS
Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
[TBL] [Abstract][Full Text] [Related]
15. Optimizing antithrombotic therapy after coronary stent implantation in patients on chronic oral anticoagulation.
Bennaghmouch N; Sprenkeler D; Qaderdan K; ten Berg JM
J Cardiovasc Transl Res; 2014 Feb; 7(1):64-71. PubMed ID: 24395496
[TBL] [Abstract][Full Text] [Related]
16. [Warfarin combined with blood platelet inhibition].
Vik-Mo H
Tidsskr Nor Laegeforen; 2011 Feb; 131(3):252-3. PubMed ID: 21304575
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacy.
Valgimigli M; Minarelli M
Am Heart J; 2010 Dec; 160(6 Suppl):S36-41. PubMed ID: 21147290
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.
Bhatt DL
Nat Rev Cardiol; 2018 Feb; 15(2):71-72. PubMed ID: 29297509
[No Abstract] [Full Text] [Related]
19. Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
Verheugt FWA
Circulation; 2018 Apr; 137(16):1655-1657. PubMed ID: 29661947
[No Abstract] [Full Text] [Related]
20. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén H; Agren A; Nekludov M
Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
